Description
A synthetic triple-agonist research peptide. Retatrutide is supplied as 10 mg of lyophilized powder in a sealed vial for in-vitro laboratory research. Every batch is third-party tested by HPLC and mass spectrometry, with a Certificate of Analysis confirming identity and ≥99% purity. Shipped ambient. Brightly performs no reconstitution and provides no usage guidance. For research use only — not for human or animal consumption.





Reviews
There are no reviews yet.